Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis

Surgery (United States)

Volumn 156, Issue 2, 2014, Pages 214-220

  Zhao, Ting ^a   Li, Yongqing ^b   Liu, Baoling ^b   Wu, Erxi ^c   Sillesen, Martin ^a,d   Velmahos, George C ^a   Halaweish, Ihab ^b   Alam, Hasan B ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NORTH DAKOTA STATE UNIVERSITY   (United States)

^d Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; HISTONE DEACETYLASE INHIBITOR; VORINOSTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CONFERENCE PAPER; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRIN FORMATION; INFLAMMATION; MALE; MOUSE; MULTIPLE ORGAN FAILURE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPH; THROMBOSIS;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRIN; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; MALE; MICE; MICE, INBRED C57BL; SEPSIS; THROMBELASTOGRAPHY;

EID: 84904252912     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.04.022     Document Type: Conference Paper

References (43)

1. J.S. Boomer, K. To, K.C. Chang, O. Takasu, D.F. Osborne, and A.H. Walton et al. Immunosuppression in patients who die of sepsis and multiple organ failure JAMA 306 2011 2594 2605
2. R.P. Wenzel, and M.B. Edmond Septic shock-evaluating another failed treatment N Engl J Med 366 2012 2122 2124
3. V.M. Ranieri, B.T. Thompson, P.S. Barie, J.F. Dhainaut, I.S. Douglas, and S. Finfer et al. Drotrecogin alfa (activated) in adults with septic shock N Engl J Med 366 2012 2055 2064
4. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138 150
5. G.T. Kinasewitz, S.B. Yan, B. Basson, P. Comp, J.A. Russell, and A. Cariou et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] Crit Care 8 2004 R82 R90
6. M. Levi, E. de Jonge, and T. van der Poll Sepsis and disseminated intravascular coagulation J Thromb Thrombolysis 16 2003 43 47
7. K. Bakhtiari, J.C. Meijers, E. de Jonge, and M. Levi Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation Crit Care Med 32 2004 2416 2421
8. J.F. Dhainaut, S.B. Yan, D.E. Joyce, V. Pettila, B. Basson, and J.T. Brandt et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation J Thromb Haemost 2 2004 1924 1933
9. C.F. Moldow, R.R. Bach, K. Staskus, and P.D. Rick Induction of endothelial tissue factor by endotoxin and its precursors Thromb Haemost 70 1993 702 706
10. S. Gando Microvascular thrombosis and multiple organ dysfunction syndrome Crit Care Med 38 2010 S35 S42
11. N. Salooja, and D.J. Perry Thrombelastography Blood Coagul Fibrinolysis 12 2001 327 337
12. L. Shore-Lesserson Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function Semin Cardiothorac Vasc Anesth 9 2005 41 52
13. K. Cvachovec, M. Horacek, and I. Vislocky A retrospective survey of fibrinolysis as an indicator of poor outcome after cardiopulmonary bypass and a possible early sign of systemic inflammation syndrome Eur J Anaesthesiol 17 2000 173 176
14. J.S. Viana, M.G. Pereira, L. Lozano, H. Vieira, A. Palmeiro, and M. Lourenco et al. Thrombelastographic evidence of hyperfibrinolysis during liver transplantation for familial amyloidotic polyneuropathy ATTR met 30 Transplant Proc 32 2000 2645 2646
15. G. Liu, J. Bowkett, G. Przybylowski, R. Bellomo, and P.L. McNicol Postoperative fibrinolysis diagnosed by thrombelastography Anaesth Intensive Care 28 2000 77 81
16. V.G. Nielsen, J.P. Crow, F. Zhou, and D.A. Parks Peroxynitrite inactivates tissue plasminogen activator Anesth Analg 98 2004 1312 1317
17. L. Rugeri, A. Levrat, J.S. David, E. Delecroix, B. Floccard, and A. Gros et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography J Thromb Haemost 5 2007 289 295
18. H.J. Tsai, C.M. Tsao, M.H. Liao, S.M. Ka, W.J. Liaw, and C.C. Wu Application of thrombelastography in liver injury induced by endotoxin in rat Blood Coagul Fibrinolysis 23 2012 118 126
19. A.O. Spiel, F.B. Mayr, C. Firbas, P. Quehenberger, and B. Jilma Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans J Thromb Haemost 4 2006 411 416
20. F. Daudel, U. Kessler, H. Folly, J.S. Lienert, J. Takala, and S.M. Jakob Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study Crit Care 13 2009 R42
21. P.W. Collins, L.I. Macchiavello, S.J. Lewis, N.J. Macartney, A.G. Saayman, and R. Luddington et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls Br J Haematol 135 2006 220 227
22. Y. Li, B. Liu, E.Y. Fukudome, A.R. Kochanek, R.A. Finkelstein, and W. Chong et al. Surviving lethal septic shock without fluid resuscitation in a rodent model Surgery 148 2010 246 254
23. T. Zhao, Y. Li, B. Liu, Z. Liu, W. Chong, and X. Duan et al. Novel pharmacologic treatment attenuates septic shock and improves long-term survival Surgery 154 2013 206 213
24. Y. Li, B. Liu, X. Gu, A.R. Kochanek, E.Y. Fukudome, and Z. Liu et al. Creating a "pro-survival" phenotype through epigenetic modulation Surgery 152 2012 455 464
25. W. Chong, Y. Li, B. Liu, T. Zhao, E.Y. Fukudome, and Z. Liu et al. Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages J Surg Res 178 2012 851 859
26. W. Chong, Y. Li, B. Liu, Z. Liu, T. Zhao, and D.R. Wonsey et al. Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study J Trauma Acute Care Surg 72 2012 347 353
27. D. Rittirsch, M.S. Huber-Lang, M.A. Flierl, and P.A. Ward Immunodesign of experimental sepsis by cecal ligation and puncture Nat Protoc 4 2009 31 36
28. J.H. Waters, D.G. Anthony, A. Gottlieb, and J. Sprung Bleeding in a patient receiving platelet aggregation inhibitors Anesth Analg 93 2001 878 882
29. I. Cinel, and S.M. Opal Molecular biology of inflammation and sepsis: a primer Crit Care Med 37 2009 291 304
30. M. Levi, M. Schultz, and T. van der Poll Disseminated intravascular coagulation in infectious disease Semin Thromb Hemost 36 2010 367 377
31. N. Semeraro, C.T. Ammollo, F. Semeraro, and M. Colucci Sepsis-associated disseminated intravascular coagulation and thromboembolic disease Mediterr J Hematol Infect Dis 2 2010 e2010024
32. M. Levi The coagulant response in sepsis Clin Chest Med 29 2008 627 642
33. D.M. Monroe, and N.S. Key The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking J Thromb Haemost 5 2007 1097 1105
34. J. Xu, X. Zhang, R. Pelayo, M. Monestier, C.T. Ammollo, and F. Semeraro et al. Extracellular histones are major mediators of death in sepsis Nat Med 15 2009 1318 1321
35. F. Leoni, A. Zaliani, G. Bertolini, G. Porro, P. Pagani, and P. Pozzi et al. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines Proc Natl Acad Sci U S A 99 2002 2995 3000
36. W.I. Lee, T.C. Yao, K.W. Yeh, L.C. Chen, L.S. Ou, J.L. Huang PATCH Study Group Stronger Toll-like receptor 1/2, 4, and 7/8 but less 9 responses in peripheral blood mononuclear cells in non-infectious exacerbated asthmatic children Immunobiology 218 2013 192 200
37. Z. Liu, Y. Li, B. Liu, D.K. Deperalta, T. Zhao, and W. Chong et al. Synergistic effects of hypertonic saline and valproic acid in a lethal rat two-hit model J Trauma Acute Care Surg 74 2013 991 997
38. Y. Li, B. Liu, E.Y. Fukudome, J. Lu, W. Chong, and G. Jin et al. Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock Surgery 150 2011 442 451
39. K. Inoue, M. Kobayashi, K. Yano, M. Miura, A. Izumi, and C. Mataki et al. Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression Arterioscler Thromb Vasc Biol 26 2006 2652 2659
40. J. Wang, S.A. Mahmud, P.B. Bitterman, Y. Huo, and A. Slungaard Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes J Biol Chem 282 2007 28408 28418
41. R.P. Hebbel, G.M. Vercellotti, B.S. Pace, A.N. Solovey, R. Kollander, and C.F. Abanonu et al. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice Blood 115 2010 2483 2490
42. U. Mahlknecht, and C. Schonbein Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells Haematologica 93 2008 443 446
43. S. Saito, J.A. Lasky, W. Guo, H. Nguyen, A. Mai, and S. Danchuk et al. Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin Biochem Biophys Res Commun 408 2011 630 634